American Heart Association
Innovative Project Award

Deadline: December 1, 2023
If invited, full application due March 8, 2024

Amount: $200,000 over two years

Career Stage: All career stages

Purpose

• To support highly innovative, high-impact research that could ultimately lead to critical discoveries or major advancements that will accelerate the field of cardiovascular and/or cerebrovascular research.
• Research deemed innovative may introduce a new paradigm, challenge current paradigms, look at existing problems from new perspectives or exhibit other uniquely creative qualities.
• The Innovative Project Award (IPA) promotes unexplored ideas; therefore, preliminary data is not required and not accepted as part of the proposal. However, a solid rationale for the work must be provided. If you provide preliminary data, the application will be disqualified.

Eligibility
The candidate must hold a post-baccalaureate PhD degree or equivalent, or a doctoral-level clinical degree, such as MD, DO, DVM, PharmD, or PhD in nursing, public health or other clinical health science.

This program places no limit on eligibility based on career stage, academic rank or discipline. It requires only evidence of employment at a qualified institution, beyond the fellowship/training stage.

---

CART (Coins for Alzheimer's Research Trust

Deadline: December 1, 2023, Letter of Intent
If invited, full application due: February 9, 2024

Funding: $300,000 over two years

Purpose:
The goal of CART is to encourage exploratory and developmental AD research projects within the United States by providing support for the early and conceptual plans of those projects that may not yet be supported by extensive preliminary data, but have the potential to substantially advance biomedical research.

Proposals should be distinct from those projects designed to increase knowledge in a well-established area unless it is intended to extend previous discoveries toward new directions or applications.

Eligibility:
Full-time faculty (or the equivalent status) at U.S.-based public and private institutions, such as universities, colleges, hospitals, and laboratories, are eligible. This is for NEW projects only.

---

Brain & Behavior Research Foundation
Distinguished Investigator Grants

Deadline: December 5, 2023

Amount: $100,000 for one year

Career Stage: Established in field

Purpose:
The Brain & Behavior Research Foundation’s Distinguished Investigator Grant program is for established scientists pursuing particularly innovative project ideas. BBRF Distinguished Investigator Grants fund talented, established scientists with a record of outstanding research accomplishments. These research projects might provide new approaches to understanding or treating severe mental illness. If successful, the grants could result in later funding from other sources. These grants are among the most competitive in mental health research and demonstrate the power of investigator-initiated research to bring out new and creative ideas.

Eligibility:

• Applicants must be a full professor (or equivalent), and maintain peer-reviewed, competitively funded scientific programs.
• Applicants may not receive the award for a second time.
• Funding is for one year and is up to $100,000. Funding of institutional overhead at an 8% rate (excluding equipment) is allowed and overhead must be included within the total budget request which may not exceed $100,000. Equipment, salary, and technical support are typical budget requests, but the Foundation wishes applicants to identify requirements specific to their research and setting.

Application Process:

• Applications must be completed and submitted online by December 5, 2023 (11:59 p.m., ET). Late submissions will not be accepted.
• Requests for further information will be made to selected investigators.
• Notification of awards will be mailed by May 2024. It is the Foundation’s policy to provide no feedback on applications, other than funding notification.

---

American Heart Association
Career Development Award

Deadline: December 6, 2023

Amount: $231,000 over three years

Purpose:
This grant supports highly promising health care and academic professionals, in the early years of their first professional appointment, to explore innovative questions or pilot studies that will provide preliminary data and training necessary to assure the applicant’s future success as a research scientist. The award will develop the research skills to support and greatly enhance the awardee’s chances to obtain and retain a high-quality career position.

Eligibility:
At the time of application, the applicant must hold an MD, PhD, DO, DVM, DDS or equivalent post-baccalaureate doctoral degree.

---

The Michael J. Fox Foundation
The Edmond J. Safra Fellowship in Movement Disorders

Deadline: December 7, 2023

Funding: $180,000 over three years

Purpose:
The Edmond J. Safra Fellowship in Movement Disorders aims to grow the global base of movement disorder specialists — neurologists with additional training in Parkinson's disease and other movement disorders — by training movement disorder clinician-researchers who can provide expert care and lead scientific advances. As the demand for movement disorder specialists increases, not enough neurologists are receiving vital training in Parkinson’s and related conditions. To address this need, the Michael J. Fox Foundation (MJFF), in collaboration with longtime partner the Edmond J. Safra Foundation, launched the Edmond J. Safra Fellowship in Movement Disorders. The program annually funds academic centers to train a new movement disorder clinician-researcher over a two-year period and is growing an international, collaborative network of next-generation leaders in Parkinson’s research and care.
Watch the recording for a program overview.

Eligibility:
The program grants funding directly to academic centers, which then must identify and train a new movement disorder clinician-researcher over a two-year period. Grant support cannot be used for a fellow already enrolled or selected. These funds may cover the fellow’s stipend, benefits and travel allowance as well as coursework, conferences and other relevant educational and training opportunities. No indirect costs may be claimed for this award.

The Edmond J. Safra Fellowship in Movement Disorders is open to academic centers worldwide. Previously awarded centers — except those that received an Edmond J. Safra Fellowship grant in the most recent funding cycle — are eligible to apply.

---

The American Brain Tumor Association

Deadline: December 13, 2023, Letter of Intent
If invited, full application due: On or around March 27, 2024

Funding: $200,000 over two years

Purpose:
The American Brain Tumor Association seeks applications from a collaborative team of two
faculty at different institutions, who propose multi-disciplinary, high-risk/high-impact projects with the potential to change current diagnostic or treatment paradigms for adult and pediatric brain tumor care.

• Grants are intended to promote team science in a way that will streamline and accelerate the development of new approaches to diagnosis and treatment, leading to advancements in the understanding and treatment of brain tumors and increasing the potential for improving, extending and ultimately saving the lives of those living with a brain tumor diagnosis.
• Grants specifically encourage innovative research by allowing research teams to conduct the early scientific studies needed to secure additional/future funding for their collaborative projects.
• The research projects supported by this mechanism must be conducted by a team of two co-principal investigators (co-PIs) from distinct institutions.
• The research project should be multidisciplinary in that it incorporates multiple components such as basic, translational, clinical and epidemiological research.
• Investigators from sciences outside traditional biological fields are encouraged to apply.

Projects may focused on all brain tumor types, benign or malignant, primary or secondary (metastatic), and that will have an impact on pediatric, adult or both populations. Appropriate research projects include, but are not limited to, the following areas:

• Biomarkers of risk, disease burden, and/or treatment response
• Brain tumor biology
• Clinical research
• Diagnosis
• Drug delivery
• Etiology
• Genetics
• Imaging
• Molecular/genetic epidemiology
• Novel therapeutics
• Risk assessment

Eligibility:

• Applicants/lead PIs, co-PIs and institutions must conform to the eligibility criteria list here to apply for an ABTA Research Collaboration Grant.
• Grants will be awarded to a lead principal investigator (PI) and co-principal investigator (co-PI) from distinct institutions. Additional co-investigators and collaborators will be considered but their contribution must be well justified and add a critical perspective or role to the project.

---

The Rita Allen Foundation
2024 Rita Allen Foundation Scholars Award in Pain

Deadline: December 14, 2023, 11:59 p.m. ET

Funding: $150,000 over three years

Career Stage: Early career leaders in basic pain research

Purpose:
Proposed research projects should be directed toward investigating the molecular biology of pain and/or basic science topics related to developing new analgesics for managing pain. The entire award is made available to projects specifically chosen by the recipient; university overhead (i.e., indirect costs) is not supported. Eligible candidates will have completed their training and provided persuasive evidence of distinguished achievement or extraordinary promise in basic research in pain. Candidates should be in the early stages of their career with an appointment at the faculty level.

Eligibility:
To be eligible for the Rita Allen Foundation Scholars Award in Pain, the applicant must:

• Have received committed start-up funds and independent laboratory space from their institution. (This information must be clearly indicated in the Department Chair/Division Chief’s letter of support for the candidate.)
• Be within three years of the start date of a tenure track position or equivalent (senior postdocs and associate professors are not eligible.)*
• Conduct their research and be appointed at an institution in the United States or Canada.
• Demonstrate a commitment to the field of pain research.

NOTE: The entire award is made available to projects specifically chosen by the recipient; university overhead (i.e., indirect costs) is not supported.

---

The Elsa U. Pardee Foundation
Innovative Cancer Research

Deadline: December 15, 2023; Next Grant Cycle: April 30, 2024

Funding: By design, there are no limits set on the amount that can be requested. It must be reasonably supported by the scope of the project outlined in the application. Indirect costs cannot exceed 5% of the total amount requested.

Career Stage: Early career, established in field, post-docs on tenure track

Purpose:
The Elsa U. Pardee Foundation funds research directed toward identifying new treatments or cures for cancer. The foundation funds projects for a one-year period which will allow the establishment of capabilities of new cancer researchers or new cancer approaches by established cancer researchers. It is anticipated that this early-stage funding by the foundation may lead to subsequent and expanded support using government agency funding. Project relevance to cancer detection, treatment, or cure should be clearly identified.

The foundation particularly welcomes innovative, small-scale, short-term projects which may be difficult to fund elsewhere until some interesting results are obtained.

Eligibility:
Post-docs who are on the tenure track and have a tenured mentor are eligible. Priority is given to researchers at nonprofit institutions in the United States who are new to the field of cancer research, or to established research investigators examining new approaches to cancer cure.

---

American Federation for Aging Research
Glenn Foundation for Medical Research and AFAR Grants for Junior Faculty

Deadline:
December 18, 2023, Letter of Intent
If invited, full application due late April 2024

Funding: Up to $150,000 for a one- to two-year award

Career Stage: Junior faculty (MDs and PhDs)

Purpose:
The major goal of this program is to assist in the development of the careers of junior investigators committed to pursuing careers in the field of aging research. GFMR and AFAR support research projects concerned with understanding the basic mechanisms of aging rather than disease-specific research. Projects investigating age-related diseases are supported if approached from the point of view of how basic aging processes may lead to these outcomes. Projects concerning mechanisms underlying common geriatric functional disorders are also encouraged, as long as these include connections to fundamental problems in the biology of aging. Projects that deal strictly with clinical problems such as the diagnosis and treatment of disease, health outcomes or the social context of aging are not eligible. Projects investigating mechanisms of, or putative therapies for, Alzheimer’s disease and related dementias, are not eligible for this award and investigators should consider applying instead to the Small Research Grant Program for the Next Generation of Researchers in Alzheimer's Disease (R03).

Eligibility
The applicant must be an independent investigator with independent research space as described in a form completed by the dean or department chair, and must be no more than 10 years beyond the start of postdoctoral research training as of July 1, 2024. For Awards funded by the GFMR preference will be given to investigators who are in the first 3 years of a faculty appointment. Exceptions to the ten year rule may be requested by emailing an NIH-style biosketch to AFAR at grants@afar.org at least one week prior to the deadline date.

---

American Federation for Aging Research
The Sagol Network GerOmic Award for Junior Faculty

Deadline:
December 18, 2023, Letter of Intent
If invited, full application due late April 2024

Funding: Up to $150,000 for a one- to two-year award.

Career Stage: Junior faculty (MDs and PhDs)

Purpose:
The major goal of this program is to assist in the development of the careers of junior investigators committed to pursuing careers in the field of aging research and ger-omics, –omics research focused on aging and/or age-related disease research in particular. Research areas supported include, but are not limited to:

• Genomics, epigenomics, proteomics, metabolomics, transcriptomics and methylomics (and other areas of -omics research) that focus on biological versus chronological aging in animals and humans.
• Comparative -omics in animals with different life spans.
• Omics of aging-related interventions and therapeutics.

Eligibility
An independent investigator with independent research space at institutions as described in a form completed by the dean or department chair, no more than ten years beyond start of postdoctoral research training as of July 1, 2024. Exceptions to the ten-year rule may be requested by emailing an NIH-style biosketch to AFAR at grants@afar.org at least one week prior to the deadline date. .

Four criteria are used to determine the merit of an application:

• Qualifications and research record of the applicant
• Quality of the proposed research as it relates to the field of ger-omics
• Excellence of the research environment
• Likelihood that the project will advance the applicant's career in aging research.

McKnight Foundation – McKnight Scholars Award
McKnight Endowment Fund for Neuroscience

Deadline: January 15, 2024

Amount:  $225,000 paid in equal installments of $75,000 in 2024, 2025, and 2026

Career Stage: Early career and emerging in field

Purpose:
The McKnight Scholar Awards are given to exceptional young scientists who are in the early stages of establishing an independent laboratory and research career. The intent of the program is to foster the commitment by these scientists to research careers that will have an important impact on the study of the brain. The program seeks to support scientists committed to mentoring neuroscientists from underrepresented groups at all levels of training. Applicants for the McKnight Scholar Award must demonstrate their ability to solve significant problems in neuroscience, which may include the translation of basic research to clinical practice. They should demonstrate a commitment to an equitable and inclusive lab environment.

Eligibility
A candidate for a McKnight Scholar Award must work as an independent investigator at a not-for-profit research institution in the United States, must hold a faculty position at the rank of assistant professor, and must have served at that rank for less than four years at the application deadline (exceptions may be made for parental leave). Those holding other titles such as research assistant professor, adjunct assistant professor, professor research track, visiting professor or instructor are not eligible, and time spent in service in those ranks does not count against the four years of service for determining eligibility.

If the host institution does not use professorial titles, a letter from a senior institutional official (e.g., dean or director of research) must confirm that the applicant has their own dedicated institutional resources, laboratory space and/or facilities. A candidate may not hold another award from the McKnight Endowment Fund for Neuroscience that would overlap in time with the Scholar Award. A candidate cannot apply in more than two rounds of competition for a Scholar Award.

---

Klingenstein Third Generation Foundation
Transformation of Mental Health Care Program

Deadline:
January 15, 2024, 11:59 pm EST
The application portal opens on November 1, 2023

Funding:
The foundation expects to make up to two grant awards. Each award will be in the amount of $100,000 per year over a two-year period, for a total of $200,000 per grant. Payment of the second year of funding is contingent on sufficient progress during the first year of the grant.

Description:
The foundation is soliciting applications for academic investigators conducting research to demonstrate the benefits of novel ways to access or deliver mental health care or prevention approaches that can be implemented at scale. This application is specifically for high-quality research that builds upon promising pilot work and will lead to a larger demonstration project. Requests for service projects and applications that primarily focus on expanding services or measuring quality within an organization will not be reviewed.

Eligibility:
Academic researchers from universities, research institutions, health systems or other settings that are positioned to provide rigorous, high-quality research focused on transforming mental and behavioral health care that improves outcomes for children and adolescents are eligible.

Investigators can be at any stage in their career but must have collected enough pilot data to inform the development of the proposed research project and must be well enough established to lead an effort such as this. For investigators who are early in their career, mentoring is strongly recommended from a more senior academic researcher who has expertise in program development and dissemination. Co-applicants/principal investigators are allowed if they reside at the same institution.

---

American Federation for Aging Research
Glenn Foundation for Medical Research Postdoctoral Fellowships in Aging Research

Deadline:
January 25, 2024, Letter of Intent
If invited, full application due mid-May 2024

Funding: $75,000 for a one-year fellowship

Career Stage: Postdoctoral fellows (MD, MD/PhD and PhD)

Purpose:
The Glenn Foundation for Medical Research (GFMR), in partnership with the American Federation for Aging Research (AFAR), created the Glenn Foundation for Medical Research Postdoctoral Fellowships in Aging Research to encourage and further the careers of postdoctoral fellows who are conducting research in the basic biology of aging, as well as translating advances in basic research from the laboratory to the clinic. The award is intended to provide significant research and training support to permit these postdoctoral fellows to become established in the field of aging.

The GFMR postdoctoral fellowship program supports research projects concerned with understanding the basic mechanisms of aging as well as projects that have direct relevance to human aging if they show the potential to lead to clinically relevant strategies that address human aging and healthspan. Projects investigating age-related diseases will be considered, but only if approached from the point of view of how basic aging processes may lead to these outcomes. Projects concerning mechanisms underlying common geriatric functional disorders such as frailty will also be considered. Projects that are strictly clinical in nature such as the diagnosis and treatment of disease, health outcomes or the social context of aging are not eligible.

Eligibility:

• The applicant must be a postdoctoral fellow (MD and/or PhD degree or equivalent) at the start date of the award (July 1, 2024).
• The proposed research must be conducted at a qualified not-for-profit setting in the United States.
• Individuals who are employees in the NIH intramural program are not eligible.
• Postdoctoral fellows in laboratories that receive support as part of a Paul F. Glenn Center for Biology of Aging Research are not eligible to apply.
• Applicants who will have received more than five years of postdoctoral training at the time of the start of the award must provide a justification for the additional training period.
• Fellows may not hold any concurrent funding for the same research project.
• Former GFMR postdoctoral fellowship awardees may apply if the criteria above are met.

The Mary Kay Ash Foundation
Innovative/Translational Cancer Research Grant

Limited Submission

Deadline: February 1, 2024

Funding: $100,000 over a two-year period, July 1, 2024 – June 30, 2026

• The total budget may not exceed $100,000 (combined indirect/direct costs)
• Equipment and travel costs must be justified
• Indirect costs must not exceed 15% of direct costs.

Budget format should follow NIH format for a two-year grant ($50,000/year) and include justification.

Purpose:
The Mary Kay Ash Foundation, a funding source for cancer research, is currently accepting applications for innovative grants for translational research of cancers affecting women, including but not limited to breast, cervical, endometrial, ovarian or uterine, or cancers predominantly affecting women. Preliminary data is not required; however it is helpful to include if available. Animal studies are allowed. However, researchers will need to indicate how their studies would impact patient care in the future should their research be successful.

Required application components:

All documents should be PDFs in NIH-format.

• Research description (6 pages max.)
• Literature references Cited (2 pages max.)
• Letters of collaboration/letters of support (3 pages max.)
• Current financial support (2 pages max.)
• NIH-format budget and justification
• NIH-format biosketch or equivalent (5 pages max.)
• If a co-PI or additional collaborators are included in your research team, please provide a brief resume for each.

Eligibility:

• One application per institution.
• Principal investigator must be appointed a full-time assistant professor or higher at the time of application submission and commit a minimum 5% effort.
• One co-PI is permitted. An NIH-format CV is required in the upload section for the co-PI. Co-PI must meet the same eligibility requirements as PI (full-time assistant professor or higher). Post-doc contributors will need to be listed as co-investigators, not co-PIs. International co-PIs are permitted with the caveat that all funds will be designated to the U.S.-based university.
• Salary cap equivalent to that of NIH ( $212,100 as of 1/1/23) is imposed.
• For all documents, please adhere to NIH-format guidelines or similar.

Contact:
For questions, contact Julia.Santosuosso@mkcorp.com.

---

PhRMA Foundation
Faculty Starter Grant - Translational Medicine

Deadline: February 1, 2024, 12 noon (ET)

Funding: $100,000

Career Stage: Early Career

Purpose:
Given the breadth of the discipline, the PhRMA Foundation's Translational Medicine Program focuses specifically on novel research that uses the "bedside to bench" approach to address unmet needs in the diagnosis, treatment and prevention of disease. The foundation seeks research proposals that focus on identifying unmet clinical needs and developing new diagnostic, experimental, and computational approaches and technologies to improve patient care and management.

Applicants should work with clinical collaborators to identify unmet clinical needs. Proposals should integrate innovative technologies, with advanced biological, chemical, diagnostic and pharmacological sciences and engineering methodologies in areas that include but not are limited to:

• Genetics (molecular, pharmaco-, population, medical)
• Genomics (functional, structural, toxico-, pharmaco-, comparative)
• Systems (biology and pharmacology)
• Pathways and networks
• Integrative biology
• Modeling and simulation
• Target identification and validation
• Biomarker identification and validation
• Molecular epidemiology
• Imaging
• Disease modeling

Eligibility

• Applicants (U.S. and non-U.S. citizens) must be full-time, promotion-eligible, research-intensive faculty employed at a PhD and/or MS degree-granting accredited U.S. university.
• Applicants must be within the first five years of independent status
• Applicants must be eligible to apply for independent external research funding by their university.
• Applicants should not have other substantial sources of research funding. Individuals receiving only intramural funding or start-up funding from their university are eligible to apply. (Applicants are ineligible if they are the principal investigator of an R01 from the National Institutes of Health or a career award from the National Science Foundation.)
• The Foundation will not consider multiple applications for the same or similar efforts on the same project. If multiple applicants are submitting proposed efforts on the same project, the efforts must be separate activities and not duplicative. This pertains to applications in both categories of our translational medicine programs (postdoctoral fellowships and faculty starter grants).

---

PhRMA Foundation
Postdoctoral Fellowships - Translational Medicine

Deadline: February 1, 2024, 12 noon (ET)

Amount:  $60,000 per year up to 2 years

Purpose:
Given the breadth of the discipline, the PhRMA Foundation’s Translational Medicine Program focuses specifically on novel research that uses the “bedside to bench” approach to address unmet needs in the diagnosis, treatment and prevention of disease. The foundation seeks research proposals that focus on identifying unmet clinical needs and developing new diagnostic, experimental, and computational approaches and technologies to improve patient care and management. Proposals should integrate innovative technologies, with advanced biological, chemical, diagnostic, and pharmacological sciences and engineering methodologies in areas that include but not are limited to:

• Genetics (molecular, pharmaco-, population, medical)
• Genomics (functional, structural, toxico-, pharmaco-, comparative)
• Systems (biology and pharmacology)
• Pathways and networks
• Integrative biology
• Modeling and simulation
• Target identification and validation
• Biomarker identification and validation
• Molecular epidemiology
• Imaging
• Disease modeling

Eligibility

• Applicants (U.S. and non-U.S. citizens) must currently be in a PhD and/or MS degree-granting accredited U.S. university.
• Applicants must have a firm commitment from a research supervisor or sponsor at their university.
• Applicants must hold a PhD, PharmD, MD or appropriate terminal research doctorate. If you do not hold one at the time of application submission, please state in your extended letter when you expect to receive it, as it must be received before funding can begin. Funding can begin as early as July 1, 2024, or as late as December 1, 2024.
• Applicants must be within their first five years of postdoctoral study at the time of award activation.
• Applicants who are applying for funds to support postdoctoral work in the laboratory where their graduate work was performed will be given lower preference. One of the objectives of this fellowship is to gain new skills and therefore an ideal candidate will be conducting their research in a new laboratory and not where their graduate work was performed.
• The Foundation will not consider multiple applications for the same or similar efforts on the same project. If multiple applicants are submitting proposed efforts on the same project, the efforts must be separate activities and not duplicative. This pertains to applications in both categories of our translational medicine program (postdoctoral fellowships and faculty starter grants).

American Federation for Aging Research
Glenn Foundation Discovery Award

Deadline:
February 15, 2024, Letter of Intent
If invited, full application due: late May, 2024

Funding: $175,000 over three years

Purpose:
The Glenn Foundation for Medical Research (GFMR) in collaboration with the American Federation for Aging Research (AFAR), has established the Glenn Foundation Discovery Award. This award was created to support research projects with strong potential to develop pioneering discoveries for understanding the underlying biological mechanisms that govern normal human aging and its related physiological decline. Relevant proposals from any branch of biology are eligible. This funding program specifically seeks to include principal investigators who may not have previously worked in the area of aging, but whose research and expertise are applicable to understanding the biological mechanisms of normal aging and its relevance to age-associated health decline. Projects that characterize aging as a disease, or that focus on specific diseases are discouraged unless the research plan provides direct connections to the biology of aging and/or the prospect of a translational discovery relevant to improving human healthspan.

Eligibility:

• Must be a full-time faculty member at the rank of assistant professor or higher at the time of the LOI deadline. To be competitive at the assistant professor level, a candidate would be expected to have established R01 or equivalent funding. The Glenn Foundation Discovery Award does not substitute for the R01 funding mechanism, but supports new, rather than incremental, research projects in established laboratories.
• Must have a strong record of independent publication beyond the postdoctoral level.
• Cannot be a principal investigator supported through the Paul F. Glenn Centers for Biology of Aging Research.
• Must conduct the proposed research at qualified not-for-profit setting in the United States.
• Investigators who may not have previously worked in the area of aging, but whose research interests and expertise are relevant and could lead to discoveries in understanding the biology of normal aging, are strongly encouraged to apply.

---

March of Dimes Foundation
Pediatric Scientist Development Program

Deadline:
Eligibility deadline: February 15, 2024
Application deadline: April 15, 2024 at 11:59 PM ET

Funding:
$250,000 over two years

Career Stage:
Early career and new faculty researchers

Areas of Research: Pediatrics and its subspecialties

Purpose:
Due to its focus on young scientists who may not have had rigorous experience or training in scientific inquiry or publication, the PSDP program is more flexible in terms of research proposals, and recipient acceptance into the program does not imply a need to conduct and publish novel, breakthrough scientific work in the pediatrics space, as this in and of itself is rare. Rather, the program is a March of Dimes effort to recognize and strengthen the wide breadth of human talent in the pediatrics field and spark a lifelong confidence, passion and commitment to fetal, neonatal and childhood health research that will undoubtedly change not only clinical outcomes, but lives, in the decades to come. As such, research proposals must be translational in nature and relate to the field of pediatrics — with a focus on prematurity, neonatal morbidity and mortality, and fetal and neonatal health equity — but the outcome of the work is less important than the training and shaping of the recipient during the grant period.

Eligibility

• Candidates must be completing or have completed pediatric residency in the U.S. or Canada.
• Candidates must be citizens or lawful permanent residents of Canada or the United States.
• The proposed research project can be categorized as basic, clinical, health services or translational research. The PSDP supports broad research training across research disciplines supported by mentors who are federally and privately funded leaders within their field. In the clinical and translational research disciplines, the PSDP strongly supports candidates who wish to acquire rigorous training in those scientific disciplines listed in the Statement on Clinical and Translational Research Training for the PSDP. For candidates with MD-PhD degrees, the PSDP gives preference to research proposals involving mentors other than those responsible for the candidate's doctoral or postdoctoral training.
• Candidates must have an MD, DO or MD-PhD degree and must be enrolled in a pediatric training program (applications may be accepted from candidates whose academic training has been interrupted prior to fellowship or who have pursued alternative career tracks and wish to re-enter academic training). Please note that a maximum of 25% of training positions are available for MD-PhD applicants each year. Candidates with PhD degrees alone are not eligible.
• The proposed mentor has an academic appointment in a department conducive to the proposed research project. The mentor should hold the rank of associate professor or higher.

---

American Federation for Aging Research
Medical Student Training in Aging Research (MSTAR) Program

Deadline:
Interested students should be in touch directly with the National Training Centers to for the program deadline and application materials.

Funding:
The stipend level is approximately $1,980 per month; actual amounts will vary based on the specific appointment period of individual students. Award period: Eight to 12 weeks.

Purpose:
The MSTAR Program provides medical students with an enriching experience in aging-related research and geriatrics, with the mentorship of top experts in the field. This program introduces students to research and academic experiences early in their training that they might not otherwise have during medical school. Positive experiences in the MSTAR program have led many physicians-in-training to pursue academic careers in aging, ranging from basic science to clinical research to health services research. They have joined the growing cadre of physicians and scientists whose specialized knowledge and skills are in great demand as our population ages.

Students participate in an eight- to twelve-week (or two- to three-month, depending on the training site) structured research, clinical and didactic program in geriatrics, appropriate to their level of training and interests. Research projects are offered in basic, translational, clinical or health services research relevant to older people. Most scholars will do their training and research during the summer months. They will also be invited to submit an abstract to present a poster at the annual meeting of the American Geriatrics Society.

Eligibility

• Any allopathic or osteopathic medical student in good standing, who will have successfully completed one year of medical school at a U.S. institution by June 2024. Evidence of good standing must be provided by the medical school registrar or dean when the student is notified of receiving the award.
• Applicants must be citizens or non-citizen nationals of the United States, or must have been lawfully admitted for permanent residence (i.e., in possession of a currently valid Alien Registration Receipt Card I-551, or some other legal verification of such status). Individuals on temporary or student visas are not eligible. Due to NIA restrictions, individuals holding PhD, MD, DVM or equivalent doctoral degrees in the health sciences are not eligible to apply to do the MSTAR Program.
• Additionally, applicants receiving a stipend or salary support from a federal source are not eligible for this program. Applicants may not hold another award or participate in another program concurrently with the MSTAR program, and must participate in the program full-time for a minimum of eight weeks and a maximum of 12 weeks.

---

Infectious Diseases Society of America
Grants for Emerging Researchers/Clinicians Mentorship Program

Career Stage: Medical Students

Amount: Not specified

Deadline: Ongoing

Description
The G.E.R.M. Program was developed to provide grants to medical students to support a longitudinal, mentored clinical learning and/or research project for up to a year on infectious diseases-related topics, including HIV, under the mentorship of an IDSA or HIVMA member. This program replaced the IDSA Medical Scholars and HIVMA Medical Students Programs.

Eligibility

• Graduate students
• Applicants must be medical students (first-, second- or third-year and those in combined degree programs, including MD/MPH and MD/PhD) from an accredited allopathic or osteopathic medical school in the U.S.